Comprehensive Financial Consultants Institutional Inc. Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Comprehensive Financial Consultants Institutional Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.6% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,536 shares of the healthcare conglomerate’s stock after acquiring an additional 220 shares during the quarter. Comprehensive Financial Consultants Institutional Inc.’s holdings in UnitedHealth Group were worth $1,749,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Richelieu Gestion SA acquired a new stake in UnitedHealth Group during the 4th quarter valued at $26,000. CGC Financial Services LLC grew its position in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares in the last quarter. True Wealth Design LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $31,000. LFA Lugano Financial Advisors SA grew its holdings in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares in the last quarter. Finally, Red Tortoise LLC raised its stake in shares of UnitedHealth Group by 45.1% in the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after purchasing an additional 23 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.6 %

Shares of UnitedHealth Group stock traded up $2.78 during trading on Tuesday, hitting $492.12. The stock had a trading volume of 3,056,843 shares, compared to its average volume of 4,255,447. The stock has a 50 day simple moving average of $498.64 and a 200 day simple moving average of $500.01. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $452.94 billion, a PE ratio of 30.08, a P/E/G ratio of 1.44 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the firm earned $6.26 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.71%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Analysts Set New Price Targets

Several brokerages recently issued reports on UNH. TD Cowen reduced their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Robert W. Baird started coverage on shares of UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price target for the company. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Tuesday. Royal Bank of Canada lowered their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Finally, JPMorgan Chase & Co. upped their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.